One of world’s leading pharmaceutical companies GlaxoSmithKline (GSK) revealed that its malaria candidate vaccine Mosquirix also known as RTS,S has landed European Medicines Agency’s (EMA) positive scientific opinion for children aged 6…
Tag: GSK
Breo Ellipta lands FDA approval for asthma treatment in US
GlaxoSmithKline plc and Theravance, Inc have announced that their drug Breo Ellipta (fluticasone furoate/vilanterol [FF/VI]) has been approved by the US Food and Drug Administration (FDA) as a once-daily treatment of asthma…
Malaria vaccine could be available as early as October this year
Final trial data for the first malaria vaccine candidate dubbed RTS,S/AS01, research for which is funded by GlaxoSmithKline Biologicals SA and the PATH Malaria Vaccine Initiative, are out and though the vaccine…